Entering text into the input field will update the search result below

Imprimis Pharmaceuticals misses by $0.07, misses on revenue

  • Imprimis Pharmaceuticals (NASDAQ:IMMY-OLD): Q1 EPS of -$0.26 misses by $0.07.
  • Revenue of $6.1M (+39.3% Y/Y) misses by $0.4M.
  • Press Release

Recommended For You

Related Stocks

SymbolLast Price% Chg
IMMY-OLD--
Imprimis Pharmaceuticals, Inc.